| Concepcion Cabantac Ochotorena, MD | |
|
335 Broad St, Manchester, CT 06040-4036 | |
| (860) 643-3200 | |
| (860) 643-3201 |
| Full Name | Concepcion Cabantac Ochotorena |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 335 Broad St, Manchester, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093883761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 035190 (Connecticut) | Primary |
| Entity Name | State Of Connecticut |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245256247 PECOS PAC ID: 8022915677 Enrollment ID: O20040319000535 |
News Archive
In today's tough economic climate, the majority of U.S. hospitals are challenged to generate low single-digit profit margins given the impact of rising supply costs, variances in supply utilization, and reduced revenue due to changes in patient volumes and payor reimbursement.
Several months into the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we still do not know much about the early evolutionary history and order of mutational events of the virus during this pandemic.
In "Epigenetics: A New Link Between Nutrition and Cancer", a recent article from Nutrition and Cancer: An International Journal, a publication of Routledge, researchers explore the possible effects that diet can have on gene expression through epigenetic mechanisms.
Shield Therapeutics, the independent specialty mineral medicines pharmaceutical company, today announces that it has completed recruitment of patients into its pivotal Phase 3 programme of ST10 for the treatment of iron-deficient anaemia. ST10 is a novel form of ferric iron taken orally.
Diagnosis of gastric cancer in the early stages is difficult because of the lack of simple and cheap methods of inspection and specific markers of gastric cancer while the symptoms of the disease are vague and tend to overlap with other common and benign conditions. Better tumor characterization and more individualized treatment planning can be expected only with the implementation of better diagnostic tools combined with advances in molecular and genetic analysis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Concepcion Cabantac Ochotorena, MD 28 Bancroft Ln, South Windsor, CT 06074-2463 Ph: (231) 880-3894 | Concepcion Cabantac Ochotorena, MD 335 Broad St, Manchester, CT 06040-4036 Ph: (860) 643-3200 |
News Archive
In today's tough economic climate, the majority of U.S. hospitals are challenged to generate low single-digit profit margins given the impact of rising supply costs, variances in supply utilization, and reduced revenue due to changes in patient volumes and payor reimbursement.
Several months into the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we still do not know much about the early evolutionary history and order of mutational events of the virus during this pandemic.
In "Epigenetics: A New Link Between Nutrition and Cancer", a recent article from Nutrition and Cancer: An International Journal, a publication of Routledge, researchers explore the possible effects that diet can have on gene expression through epigenetic mechanisms.
Shield Therapeutics, the independent specialty mineral medicines pharmaceutical company, today announces that it has completed recruitment of patients into its pivotal Phase 3 programme of ST10 for the treatment of iron-deficient anaemia. ST10 is a novel form of ferric iron taken orally.
Diagnosis of gastric cancer in the early stages is difficult because of the lack of simple and cheap methods of inspection and specific markers of gastric cancer while the symptoms of the disease are vague and tend to overlap with other common and benign conditions. Better tumor characterization and more individualized treatment planning can be expected only with the implementation of better diagnostic tools combined with advances in molecular and genetic analysis.
› Verified 3 days ago